Reviono, Reviono, et al. “Effectiveness of Zingiber Officinale to Reduce Inflammation Markers and the Length of Stay of Patients With Community-Acquired Pneumonia: An Open-Label Clinical Trial”. Narra J, vol. 3, no. 1, May 2023, p. e142, doi:10.52225/narra.v3i1.142.